By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Loxo Oncology 

1 Landmark Square
Suite 1122
Stamford  Connecticut  06901  U.S.A.
Phone: 203-653-3880 Fax: n/a


Company News
Loxo Oncology (LOXO) Announces FDA Orphan Drug Designation Granted To LOXO-101 For Treatment Of Soft Tissue Sarcoma 9/2/2015 7:25:08 AM
Loxo Oncology (LOXO) Announces Second Quarter 2015 Financial Results And Provides Program Updates 8/5/2015 10:25:27 AM
Loxo Oncology (LOXO) Appoints Industry Veteran Tim Mayleben To Board Of Directors 7/30/2015 7:05:47 AM
Loxo Oncology (LOXO) To Conduct Conference Call And Webcast Of Second Quarter Financial Results 7/29/2015 8:59:23 AM
University of Colorado Cancer Center And Loxo Oncology (LOXO) Announce Publication That Provides Clinical Validation For LOXO-101 Against TRK Fusion Cancer 7/28/2015 7:14:50 AM
Loxo Oncology (LOXO) To Present At The JMP Securities Life Sciences Conference 6/17/2015 8:46:26 AM
Loxo Oncology (LOXO) Announces First Quarter 2015 Financial Results 5/14/2015 8:49:36 AM
Loxo Oncology (LOXO)'s LOXO-101 Demonstrates Encouraging Initial Results From Ongoing Phase Ia Dose Escalation Study 4/21/2015 12:39:46 PM
Loxo Oncology (LOXO) Announces Fourth Quarter And Year-End 2014 Financial Results 3/27/2015 6:51:59 AM
Loxo Oncology (LOXO) Announces 2015 Program Guidance And Reveals Selected Pipeline Programs 3/2/2015 7:28:17 AM